Clinical Trial Update: A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, pharmacodynamics, pharmacokinetics, and efficacy of ARGX-113 in patients with pemphigus vulgaris and pemphigus foliaceus has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pemphigus Foliaceus
• Pemphigus Vulgaris

Drugs mentioned

• ARGX-113

Snippet

Sponsor: argenx | Conditions: Pemphigus Vulgaris, Pemphigus Foliaceus | Phase 2 | Status: COMPLETED